Home▸Articles▸Master Protocol & Adaptive Trial Design

Basket Trial Multi-Tumor Design: A Strategic Approach for Cancer Research

A basket trial design allows researchers to efficiently test a single treatment across multiple tumor types with shared genetic characteristics.

mysimulator teamUpdated June 2026≈ 3 min read▶ Open the simulation

What is a Basket Trial?

A basket trial is a type of clinical trial design where patients with different types of cancers are enrolled based on the presence of a specific genetic alteration rather than the site or type of cancer. This approach allows for the evaluation of a single investigational treatment in multiple tumor types that share a common driver mutation.

The term 'basket' refers to the grouping of various tumors under one trial, much like items being placed into a basket.

Why Use Multi-Tumor Basket Designs?

Multi-tumor basket designs are particularly advantageous because they can accelerate the development of targeted therapies by reducing the time and resources required to conduct separate trials for each tumor type.

By pooling patients with similar genetic alterations, researchers can gather more robust data on a treatment's efficacy and safety across different cancer types.

live demo · related simulation● LIVE

Principles Governing Basket Trials

The success of basket trials relies on the identification of common driver mutations that are present in multiple tumor types. These mutations serve as biomarkers for patient selection, ensuring that only those likely to benefit from the treatment are included.

Statistical methods and adaptive trial designs are crucial for managing the complexity and variability inherent in multi-tumor basket trials, allowing for flexible adjustments based on interim data analysis.

Real-World Applications of Basket Trials

Basket trials have been instrumental in advancing precision medicine by identifying effective treatments for patients with rare or difficult-to-treat cancers. For example, the use of vemurafenib in melanoma and colorectal cancer has demonstrated the potential of this approach.

The FDA has approved several drugs based on basket trial data, highlighting their importance in modern oncology research.

Frequently asked questions

How does a basket trial differ from a traditional tumor-specific trial?

A basket trial focuses on patients with the same genetic alteration across different cancer types, whereas a traditional tumor-specific trial targets patients based solely on their primary cancer type.

What are the main challenges in conducting multi-tumor basket trials?

Challenges include ensuring adequate patient enrollment from diverse tumor types, managing statistical complexity due to heterogeneity across different cancers, and addressing ethical considerations related to patient selection criteria.

Can a single treatment be effective for all the tumors in a multi-tumor basket trial?

While some treatments may show efficacy across multiple tumor types with shared genetic alterations, others might not. The results from each tumor type need to be carefully analyzed to determine the true effectiveness and potential side effects.

How do researchers decide which genetic alterations to target in a basket trial?

Researchers typically identify common driver mutations through large-scale genomic studies, such as those conducted by The Cancer Genome Atlas (TCGA), which provide insights into the molecular landscape of various cancers.

Try it live

Everything above runs in your browser — open Basket Trial Multi-Tumor Design and change the parameters while it is running. Nothing is installed, nothing is uploaded, the whole model lives in one tab.

▶ Open Basket Trial Multi-Tumor Design simulation

What did you find?

Add reproduction steps (optional)